Spots Global Cancer Trial Database for malignant glioma, recurrent
Every month we try and update this database with for malignant glioma, recurrent cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma | NCT00024570 | Malignant Gliom... Glioblastoma Mu... Anaplastic Astr... Mixed Oligoastr... | IL13-PE38QQR targeted fusion... surgery | 18 Years - | INSYS Therapeutics Inc | |
Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients | NCT00024557 | Malignant Gliom... Glioblastoma Mu... Anaplastic Astr... Mixed Oligoastr... Malignant Astro... | IL13-PE38QQR targeted fusion... surgery | 18 Years - | INSYS Therapeutics Inc | |
Interstitial Infusion of IL13-PE38QQR Cytotoxin in Recurrent Malignant Glioma | NCT00024570 | Malignant Gliom... Glioblastoma Mu... Anaplastic Astr... Mixed Oligoastr... | IL13-PE38QQR targeted fusion... surgery | 18 Years - | INSYS Therapeutics Inc |